Estrella Immunopharma
$0.6400
5
-$0.01-0.97% 20:00 Today
+$0.00+0.05%20:00After hours
Statistics
Day High
0.707
Day Low
0.62
52W High
3.15
52W Low
0.585
Volume
53,691
Avg. Volume
36,975
Mkt Cap
27.84M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
2DecExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.19
-0.14
-0.1
-0.05
Expected EPS
-0.08
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-13.06MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ESLA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Show more...
CEO
Cheng Liu
Employees
3
Country
United States
ISIN
US2975841048
Listings
0 Comments
Share your thoughts
FAQ
What is Estrella Immunopharma stock price today?▼
The current price of ESLA is $0.64 USD — it has decreased by -0.97% in the past 24 hours. Watch Estrella Immunopharma stock price performance more closely on the chart.
What is Estrella Immunopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Estrella Immunopharma stocks are traded under the ticker ESLA.
Is Estrella Immunopharma stock price growing?▼
ESLA stock has fallen by -7.45% compared to the previous week, the month change is a -11.42% fall, over the last year Estrella Immunopharma has showed a -36% decrease.
What is Estrella Immunopharma market cap?▼
Today Estrella Immunopharma has the market capitalization of 27.84M
When is the next Estrella Immunopharma earnings date?▼
Estrella Immunopharma is going to release the next earnings report on December 02, 2026.
What were Estrella Immunopharma earnings last quarter?▼
ESLA earnings for the last quarter are -0.05 USD per share, whereas the estimation was -0.05 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Estrella Immunopharma revenue for the last year?▼
Estrella Immunopharma revenue for the last year amounts to 0 USD.
What is Estrella Immunopharma net income for the last year?▼
ESLA net income for the last year is -13.06M USD.
How many employees does Estrella Immunopharma have?▼
As of September 08, 2026, the company has 3 employees.
In which sector is Estrella Immunopharma located?▼
Estrella Immunopharma operates in the Health & Wellness sector.
When did Estrella Immunopharma complete a stock split?▼
Estrella Immunopharma has not had any recent stock splits.
Where is Estrella Immunopharma headquartered?▼
Estrella Immunopharma is headquartered in EMERYVILLE, United States.